Processing

Please wait...

Settings

Settings

Goto Application

1. WO2011007792 - ENZYME COMPOSITION

Publication Number WO/2011/007792
Publication Date 20.01.2011
International Application No. PCT/JP2010/061870
International Filing Date 14.07.2010
IPC
A61K 38/44 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
44Oxidoreductases (1)
A23L 1/30 2006.01
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D91; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
1Foods or foodstuffs; Their preparation or treatment
29Modifying nutritive qualities of foods; Dietetic products
30containing additives
A61K 9/22 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, lozenges or tablets
22Sustained or differential release type
A61K 9/52 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
48Preparations in capsules, e.g. of gelatin, of chocolate
52Sustained or differential release type
A61P 3/04 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
04Anorexiants; Antiobesity agents
A61P 3/10 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
3Drugs for disorders of the metabolism
08for glucose homeostasis
10for hyperglycaemia, e.g. antidiabetics
CPC
A23L 29/06
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
29Foods or foodstuffs containing additives
06Enzymes
A23L 33/135
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A23B - A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT
33Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
10using additives
135Bacteria or derivatives thereof, e.g. probiotics
A23V 2002/00
AHUMAN NECESSITIES
23FOODS OR FOODSTUFFS; THEIR TREATMENT, NOT COVERED BY OTHER CLASSES
VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES
2002Food compositions, function of food ingredients or processes for food or foodstuffs
A61K 38/44
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
44Oxidoreductases (1)
A61K 38/443
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
38Medicinal preparations containing peptides
16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
43Enzymes; Proenzymes; Derivatives thereof
44Oxidoreductases (1)
443acting on CH-OH groups as donors, e.g. glucose oxidase, lactate dehydrogenase (1.1)
A61K 9/2806
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
9Medicinal preparations characterised by special physical form
20Pills, tablets, ; discs, rods
28Dragees; Coated pills or tablets ; , e.g. with film or compression coating
2806Coating materials
Applicants
  • 天野エンザイム株式会社 AMANO ENZYME INC. [JP]/[JP] (AllExceptUS)
  • 西尾 享一 NISHIO Kyouichi [JP]/[JP] (UsOnly)
  • 井戸 宏樹 IDO Hiroki [JP]/[JP] (UsOnly)
Inventors
  • 西尾 享一 NISHIO Kyouichi
  • 井戸 宏樹 IDO Hiroki
Agents
  • 西尾 章 NISHIO Akira
Priority Data
2009-16934817.07.2009JP
Publication Language Japanese (JA)
Filing Language Japanese (JA)
Designated States
Title
(EN) ENZYME COMPOSITION
(FR) COMPOSITION D'ENZYME
(JA) 酵素組成物
Abstract
(EN)
Disclosed is an enzyme composition which causes reduction in glucose in the stomach and/or intestine, through an enzymatic reaction, to thereby reduce calorie intake when administered to a living organism, and which converts glucose into gluconic acid. Specifically disclosed is an enzyme composition comprising at least one oxidoredcutase selected from among flavin adenine dinucleotide-binding glucose dehydrogenase, glucose oxidase, NAD(P)-dependent glucose dehydrogenase and pyroloquinoline quinone-dependent glucose dehydrogenase, characterized by, when administered to a living organism, capable of reducing glucose in the stomach and/or intestine. Also disclosed are a digestive enzyme preparation, a supplement and a starting material for health foods, each containing the aforesaid enzyme composition.
(FR)
L'invention porte sur une composition d'enzyme qui provoque la réduction du glucose dans l'estomac et/ou l'intestin, par l'intermédiaire d'une réaction enzymatique, pour ainsi réduire l'apport calorique lorsqu'elle est administrée à un organisme vivant, et qui convertit le glucose en acide gluconique. L'invention porte spécifiquement sur une composition d'enzyme comprenant au moins une oxydoréductase choisie parmi la glucose déshydrogénase se liant à la flavine adénine dinucléotide, la glucose oxydase, la glucose déshydrogénase dépendante du NAD(P) et la glucose déshydrogénase dépendante de la pyroloquinoline quinone, caractérisée en ce que lorsqu'elle est administrée à un organisme vivant, elle est capable de réduire le glucose dans l'estomac et/ou l'intestin. L'invention porte également sur une préparation d'enzyme digestive, sur un supplément et sur une matière de départ pour des aliments de santé, chacun contenant la composition d'enzyme précitée.
(JA)
 酵素反応を利用し、摂取により胃内及び/又は腸内のグルコースを低減してカロリーの摂取を低減し、またグルコースをグルコン酸に変換する酵素組成物を提供する。 酸化還元酵素のフラビンアデニンジヌクレオチド結合型グルコース脱水素酵素、グルコースオキシダーゼ、NAD(P)依存型グルコース脱水素酵素及びピロロキノリンキノン依存型グルコース脱水素酵素から選ばれる1種以上を含み、摂取により胃内及び/又は腸内のグルコースを低減させることを特徴とする酵素組成物。該酵素組成物を含む消化酵素剤、サプリメント又は健康食品の原料。
Latest bibliographic data on file with the International Bureau